Zheng Y - Search Results

1

Human membrane protein Tim-3 facilitates hepatitis A virus entry into target cells.

Sui L, Zhang W, Chen Y, Zheng Y, Wan T, Zhang W, Yang Y, Fang G, Mao J, Cao X. Sui L, et al. Among authors: zheng y. Int J Mol Med. 2006 Jun;17(6):1093-9. Int J Mol Med. 2006. PMID: 16685421

2

Molecular cloning and characterization of a novel V-ATPase associated protein, DVA9.2, from human dendritic cells.

Liu X, Wang C, Li N, Zhang X, Zheng Y, Cao X. Liu X, et al. Among authors: zheng y. Life Sci. 2006 Oct 4;79(19):1828-38. doi: 10.1016/j.lfs.2006.06.028. Epub 2006 Jun 22. Life Sci. 2006. PMID: 16904702

3

TLR4 signaling induces functional nerve growth factor receptor p75NTR on mouse dendritic cells via p38MAPK and NF-kappa B pathways.

Jiang Y, Chen G, Zheng Y, Lu L, Wu C, Zhang Y, Liu Q, Cao X. Jiang Y, et al. Among authors: zheng y. Mol Immunol. 2008 Mar;45(6):1557-66. doi: 10.1016/j.molimm.2007.10.008. Epub 2007 Nov 19. Mol Immunol. 2008. PMID: 18006062

4

Rapamycin reverses TLR4 signaling-triggered tumor apoptosis resistance by disrupting Akt-mediated Bcl-xL upregulation.

Sun Q, Zheng Y, Liu Q, Cao X. Sun Q, et al. Among authors: zheng y. Int Immunopharmacol. 2008 Dec 20;8(13-14):1854-8. doi: 10.1016/j.intimp.2008.08.009. Epub 2008 Sep 21. Int Immunopharmacol. 2008. PMID: 18789402

5

Corrigendum to "Rapamycin suppresses TLR4-triggered IL-6 and PGE₂ production of colon cancer cells by inhibiting TLR4 expression and NF-κB activation" [Mol. Immunol. 45 (2008) 2929-2936].

Sun Q, Liu Q, Zheng Y, Cao X. Sun Q, et al. Among authors: zheng y. Mol Immunol. 2020 May 17;122:222. doi: 10.1016/j.molimm.2020.05.003. Online ahead of print. Mol Immunol. 2020. PMID: 32434116 No abstract available.

6

A novel endogenous human CaMKII inhibitory protein suppresses tumor growth by inducing cell cycle arrest via p27 stabilization.

Wang C, Li N, Liu X, Zheng Y, Cao X. Wang C, et al. Among authors: zheng y. J Biol Chem. 2008 Apr 25;283(17):11565-74. doi: 10.1074/jbc.M800436200. Epub 2008 Feb 27. J Biol Chem. 2008. Retraction in: J Biol Chem. 2021 Jan-Jun;296:100765. doi: 10.1016/j.jbc.2021.100765 PMID: 18305109 Free PMC article. Retracted.

7

Rapamycin suppresses TLR4-triggered IL-6 and PGE(2) production of colon cancer cells by inhibiting TLR4 expression and NF-kappaB activation.

Sun Q, Liu Q, Zheng Y, Cao X. Sun Q, et al. Among authors: zheng y. Mol Immunol. 2008 May;45(10):2929-36. doi: 10.1016/j.molimm.2008.01.025. Epub 2008 Mar 17. Mol Immunol. 2008. PMID: 18343502

8

Tumor-educated CD11bhighIalow regulatory dendritic cells suppress T cell response through arginase I.

Liu Q, Zhang C, Sun A, Zheng Y, Wang L, Cao X. Liu Q, et al. Among authors: zheng y. J Immunol. 2009 May 15;182(10):6207-16. doi: 10.4049/jimmunol.0803926. J Immunol. 2009. PMID: 19414774

9

The cytosolic nucleic acid sensor LRRFIP1 mediates the production of type I interferon via a beta-catenin-dependent pathway.

Yang P, An H, Liu X, Wen M, Zheng Y, Rui Y, Cao X. Yang P, et al. Among authors: zheng y. Nat Immunol. 2010 Jun;11(6):487-94. doi: 10.1038/ni.1876. Epub 2010 May 9. Nat Immunol. 2010. PMID: 20453844

10

Corrigendum to "Rapamycin reverses TLR4 signaling-triggered tumor apoptosis resistance by disrupting Akt-mediated Bcl-xL upregulation" [Int. Immunopharmacol. 8 (2008) 1854-1858].

Sun Q, Zheng Y, Liu Q, Cao X. Sun Q, et al. Among authors: zheng y. Int Immunopharmacol. 2020 Apr;81:106193. doi: 10.1016/j.intimp.2020.106193. Epub 2020 Mar 3. Int Immunopharmacol. 2020. PMID: 32139322 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37,361 results

Search Page

Filters